Heterocycle-containing carboxylic acid derivative and drug...

Details Heterocycle-containing carboxylic acid derivative and drug... Heterocycle-containing carboxylic acid derivative and drug...

2005-04-26

2005-04-26

Powers, Fiona T. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S314000, C546S153000, C546S157000, C546S167000, C546S173000, C546S174000, C546S175000

Reexamination Certificate

active

06884808

ABSTRACT:
Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I):wherein A represents, for example, a heteroaryl group which contains at least one nitrogen atom and may have a substituent, B represents, for example, a heteroarylene group, a —CONH— group or a group represented by the formula —CR6═CR7— in which R6and R7represents H, a lower alkyl group or the like, D represents an arylene group, a heteroarylene group or the like, n1 stands for 0 or 1, M represents, for example, a hydroxyl group or a lower alkoxy group; or a physiologically acceptable salt thereof. As a retinoic-related compound replacing retinoic acid, it permits the provision of a preventive and/or therapeutic for various diseases.

REFERENCES:
patent: 3345372 (1967-10-01), Hanifin, Jr. et al.
patent: 4036837 (1977-07-01), Sellstedt et al.
patent: 4518602 (1985-05-01), Terao et al.
patent: 4612321 (1986-09-01), Terao et al.
patent: 4703110 (1987-10-01), Shudo
patent: 4853027 (1989-08-01), Patel et al.
patent: 4879295 (1989-11-01), Yoshinaga et al.
patent: 4977276 (1990-12-01), Berlin et al.
patent: 4987146 (1991-01-01), Rohde et al.
patent: 5120745 (1992-06-01), Jacobsen et al.
patent: 5391766 (1995-02-01), Klaus et al.
patent: 5420145 (1995-05-01), Shudo
patent: 5420273 (1995-05-01), Klaus et al.
patent: 5668175 (1997-09-01), Evans et al.
patent: 0 122 388 (1984-10-01), None
patent: 300688 (1989-01-01), None
patent: 0 382 077 (1990-08-01), None
patent: 0 384 450 (1990-08-01), None
patent: 0 790 228 (1997-08-01), None
patent: 58-219162 (1983-12-01), None
patent: 59-139379 (1984-08-01), None
patent: 59-157044 (1984-09-01), None
patent: 60-58981 (1985-04-01), None
patent: 62-030172 (1987-09-01), None
patent: 62-256831 (1987-11-01), None
patent: 63-54369 (1988-03-01), None
patent: 63-1194525 (1988-05-01), None
patent: 05 078315 (1993-03-01), None
patent: 9724116 (1997-07-01), None
Atwell et al., Journal of Medicinal Chemistry, 10(4), 706-713, 1967.*
Khim.-Farm. Zh. 12 (7), (1978) p. 71-77 Oleinik et al Synthesis and antileishmaniasis activity of arylfurylquinoxalines.
Chemical Abstract 88 (23) (1978) p. 513 Szucs et al “Derivatives of alpha-and beta-unsaturated ketones derived from acetylpridine. VIII Spectral properties of some pyriding analogs of 1,3,5-triphenyl-2-pyrazoline” & Acta Fac. Pharm. Univ. comenianae, 30 (1977) p. 127-146.
Chemical Abstract, 74 (21), (1971) p. 125 Iyer, et al “p-aminosalicylic acid derivatives as possible tuberculostats” & Indian J. Chem., 8 (11), (1970), p. 964-968.
Heterocycles, 35(2) 1993 p. 975-995, Wasserman et al “Synthesis and characterization of pyrrolinonecaroxylates formed by reaction of vivinal tricarbonyl derivatives with aldehyde schiff bases”.
J. Med. Chem., 11(2), (1968), p. 295-300, Atwell et al “Potential antitumor agents”.
J. Org. Chem., 60 (25), (1925), p. 8231-5, Wasserman et al “Selective Oxidation of phosphorus ylides by dimethyldioxirane application to the formation of vicinal tricarbonyls”.
Crettaz et al Biochem. J. (1990) 272, 391-397 Ligand specificities of recombinant retinoic acid receptors RARα and RARβ.
Sani et al Archives of Biochemistry and Biophysics vol. 283, No. 1, Nov. 15, pp. 107-113, 1990 “Isolation, Partial Purification and Characterization of Nuclear Retinoic Acid Receptors from Chick Skin”.
Shudo et al, “Structural Evolution of Retinoids”, Advances in Drug Research, Academic Press, vol. 24, 1993, pp. 81-119; XP000576447.
Dawson et al, “Conformational Effects on Retinoid Receptor Selectivity. 2. Effects of Retinoid Bridging Group on Retinoid X Receptor Activity and Selectivity”, Journal of Medicinal Chemistry, American Chemical Society, vol. 38, No. 17, 1995, pp. 3368-3383; XP002148373.
Yamaguchi et al, Chemical Abstracts 120:134401, 1994.
Takasugi et al, Chemical Abstracts, 116:235661, 1992.
Ohta et al, Chemical Abstracts, 115:135786, 1991.
Ueta et al, Chemical Abstracts, 118:104658, 1993.
Makino et al, Chemical Abstracts, 113:40627, 1990.
Ohta et al, Chemical Abstracts, 112:76542, 1990.
Akita et al, Chemical Abstracts, 110:57620, 1989.
Niino et al, Chemical Abstracts, 109:116543, 1988.
Yoshinaga et al, Chemical Abstracts, 109:54782, 1988.
Koren et al, Chemical Abstracts, 108:494482, 1988.
Sato et al, Chemical Abstracts, 106:196048, 1987.
Nisato et al, Chemical Abstracts, 99:38231, 1983.
Hawksworth et al, Chemical Abstracts, 83:188835, 1975.
Stokbroekx et al, Chemical Abstracts, 114:164268, 1991.
Akiyama e al, Chemical Abstracts, 126:89368, 1997.
Omran et al, Chemical Abstracts, 108:131443, 1988.
Daidone et al, J. Heterocyclic Chem., 19(3), 689-690, 1982.
Harhash et al, Tetrahedron, 31(1), 25-29, 1975.
Parlow et al, J. Org. Chem., 62(17), 5908-5919, 1997.
Sugiura et al, J. Med. Chem., 20(1), 80-85, 1977.
Warrell et al., “Acute Promyelocytic Leukemia”, New Eng. J. Med., 329(3), 177-189, 1993.
Degos, L., “Is Acute Promyelocyctic Leukemia a Curable Disease? Treatment Strategy for a Long-Term Survival”, Leukemia, 9(6), 1994, 911-913.
Niculescu-Duvaz et al Carcinogenesis vol. 6 No. 4 pp 479-486, 1985 QSAR application in chemical caracinogenesis II. QSAR analysis of a class of carcinogensis inhibitor, retinoids.

Affiliated with

Also associated with

Rating

Heterocycle-containing carboxylic acid derivative and drug... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocycle-containing carboxylic acid derivative and drug..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycle-containing carboxylic acid derivative and drug... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3410512